IGF-1R targeting increases the antitumor effects of DNA-damaging agents in SCLC model: an opportunity to increase the efficacy of standard therapy
IGF-1R 靶向作用可增强 SCLC 模型中 DNA 损伤剂的抗肿瘤作用：为提高标准疗法的疗效提供了机会
期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-12-1067
Charles Ferté, Yohann Loriot, Céline Clémenson, Frederic Commo, Andrea Gombos, Jean-Emmanuel Bibault, Ingrid Fumagalli, Saad Hamama, Nathalie Auger, Benoit Lahon, Cyrus Chargari, Julien Calderaro, Jean-Charles Soria, Eric Deutsch
